Public deliverables

Governance structure, roles and decision-making procedures for the consortium.

The full protocol for the multinational Phase I/II trial evaluating ibrilatazar in paediatric patients with relapsed or refractory solid tumours. It defines the eligibility criteria, the dose-escalation and expansion design, the combination arms with chemotherapy and immunotherapy, the primary and secondary endpoints, the safety-monitoring framework, and the ethical and regulatory approvals required across all participating clinical sites and countries.

How research data is collected, stored, shared and preserved across the project, following the FAIR principles and in line with GDPR and open-science requirements.